Leap Investments’s Elevance Health ELV Stock Holding History

Leap Investments’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$868K	Buy	+3,300	New	+$880K	0.57%	31

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Leap Investments's ELV Position: Q2 2020 in Review

Leap Investments opened a new position in Elevance Health (ELV) in Q2 2020: 3,300 shares worth $868K. The stake represents 0.57% of the portfolio and ranks #31 among its holdings.

1,106 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

Leap Investments held 3,300 shares of Elevance Health worth $868K as of Q2 2020.
Elevance Health was a new Leap Investments position in Q2 2020.
Elevance Health made up 0.57% of Leap Investments's portfolio in Q2 2020, its #31 holding.
1,106 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.